Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

A quick analysis that compared (RPHM) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.

Company Price Change Volume, Avg. Market Cap. Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding
- - Average - - - - - - - -
Maximum - - - - - - - -
Minimum - - - - - - - -
Vir Biotechnology, Inc. VIR 7.12 0.17 2.45% 891 vs. 1,013 980.00 56.00 -65.00 -111.00 -303.00 -0.4800 -5.2847 0.0000 0.9188 -1.1579 -0.0422 -0.0364 12.4686 137.00
Royalty Pharma plc RPRX 26.43 0.03 0.11% 2,377 vs. 2,328 11,742.00 567.00 4.00 583.00 2,427.00 0.0106 701.8537 0.0070 -0.0275 0.0084 0.0007 0.0003 12.4802 444.00
Apellis Pharmaceuticals, Inc. APLS 30.77 3.02 10.88% 2,660 vs. 2,876 3,827.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for RPHM and its peers to uncover potential buy and sell opportunities.
End of RPHM's Analysis
CIK: 1637715 CUSIP: - LEI: - UEI: -
Secondary Listings
RPHM has no secondary listings inside our databases.